These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 32425261)

  • 1. Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.
    Galeano-Valle F; Oblitas CM; Ferreiro-Mazón MM; Alonso-Muñoz J; Del Toro-Cervera J; di Natale M; Demelo-Rodríguez P
    Thromb Res; 2020 Aug; 192():113-115. PubMed ID: 32425261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus Anticoagulant in Patients with Covid-19. Reply.
    Platton S; Bowles L; Pasi KJ
    N Engl J Med; 2020 Nov; 383(19):1893-1894. PubMed ID: 33095522
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to "Lupus anticoagulant is frequent in patients with Covid-19" (JTH-2020-00483).
    Tang N
    J Thromb Haemost; 2020 Aug; 18(8):2065-2066. PubMed ID: 32379935
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.
    Mantovani Cardoso E; Hundal J; Feterman D; Magaldi J
    Clin Rheumatol; 2020 Sep; 39(9):2811-2815. PubMed ID: 32720260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
    Aubignat M; Godefroy O
    Rev Neurol (Paris); 2020 Jun; 176(6):505-506. PubMed ID: 32409176
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19.
    Gemcioglu E; Erden A; Davutoglu M; Karabuga B; Kucuksahin O
    J Clin Rheumatol; 2020 Sep; 26(6):236-237. PubMed ID: 32694351
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).
    Reyes Gil M; Barouqa M; Szymanski J; Gonzalez-Lugo JD; Rahman S; Billett HH
    JAMA Netw Open; 2020 Aug; 3(8):e2017539. PubMed ID: 32785632
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
    Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
    Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19).
    Gutiérrez López de Ocáriz X; Castro Quismondo N; Vera Guerrero E; Rodríguez Rodríguez M; Ayala Díaz R; Martínez López J
    Int J Lab Hematol; 2020 Dec; 42(6):e280-e282. PubMed ID: 32851784
    [No Abstract]   [Full Text] [Related]  

  • 10. Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.
    Spyropoulos AC; Weitz JI
    Circulation; 2020 Jul; 142(2):129-132. PubMed ID: 32658609
    [No Abstract]   [Full Text] [Related]  

  • 11. Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.
    Di Micco P; Russo V; Lodigiani C
    Medicina (Kaunas); 2020 Sep; 56(10):. PubMed ID: 32992511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cautious interpretation of antiphospholipid antibodies in COVID-19.
    Mehta S; Bhandari S; Mehta S
    Clin Chim Acta; 2020 Oct; 509():166. PubMed ID: 32553721
    [No Abstract]   [Full Text] [Related]  

  • 13. Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
    Parodi A; Gasparini G; Cozzani E
    J Am Acad Dermatol; 2020 Sep; 83(3):e249. PubMed ID: 32505779
    [No Abstract]   [Full Text] [Related]  

  • 14. [Venous thromboembolism in patients with COVID-19].
    Hellfritzsch M; Kümler T; Hansen AT; Tang M; Berthelsen KG; Fialla AD; Andersen AS; Kampmann P; Hvas AM
    Ugeskr Laeger; 2020 Jun; 182(23):. PubMed ID: 32515339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus anticoagulant is frequent in patients with Covid-19.
    Harzallah I; Debliquis A; Drénou B
    J Thromb Haemost; 2020 Aug; 18(8):2064-2065. PubMed ID: 32324958
    [No Abstract]   [Full Text] [Related]  

  • 16. Venous thromboembolism in COVID-19 patients.
    Porfidia A; Pola R
    J Thromb Haemost; 2020 Jun; 18(6):1516-1517. PubMed ID: 32294289
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter by Hamilton et al Regarding Article, "Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients".
    Hamilton DO; Waite AAC; Welters ID
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):e309-e310. PubMed ID: 33085522
    [No Abstract]   [Full Text] [Related]  

  • 18. Lupus Anticoagulant in Patients with Covid-19.
    Gooding R; Myers B; Salta S
    N Engl J Med; 2020 Nov; 383(19):1893. PubMed ID: 33095521
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombosis and COVID-19 pneumonia: the clot thickens!
    Price LC; McCabe C; Garfield B; Wort SJ
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32554532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of venous thromboembolism during the COVID-19 pandemic.
    Skeik N; Mirza A; Manunga J
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):897-898. PubMed ID: 32454238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.